Translational Lung Cancer Research

Official partner

Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) is an international, peer-reviewed, open-access journal, which was founded in March 2012. TLCR is indexed by Science Citation Index Expanded (SCIE) (2020 impact factor: 6.498), PubMed/PubMed Central, Scopus and the Chemical Abstracts Service (CAS) Databases. It is published quarterly (Mar. 2012 - Jan. 2013), bimonthly (Feb. 2013 - Dec. 2020), monthly (Jan. 2021 -) and openly distributed worldwide. It provides practical up-to-date information on prevention, early detection, diagnosis, and treatment of lung cancer and related thoracic diseases. Specific areas of its interest include, but not limited to, multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.

TLCR is dedicated to focus on cutting-edge developments at the transition from preclinical to clinical research and thus closes the gap between “bench and bedside”. The aim of TLCR is to provide a forum for the dissemination of original research and review articles in all areas related to lung cancer, as well as a timely platform for the exchange of key opinions between leading experts, and so to provide readers with a novel, well-organized, informative, enlightening and educational journal.

TLCR features a distinguished editorial board, which brings together a team of highly experienced specialists in lung cancer. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of lung cancer subjects. The entire submission and review process are managed through the OJS system, an electronic journal system which offers an efficient way and ensures a rapid turnaround of papers submitted for publication. Articles can be published both online and in print when necessary. See more at Information for Authors.

TLCR is endorsed by:

• Spanish Lung Cancer Group(SLCG); • Bonnie J. Addario Lung Cancer Foundation (ALCF); • Brazilian Society of Thoracic Surgery (SBCT)

TLCR is the Official Publication of:

• General Hospital of Eastern Theater Command, Nanjing, China • Society for Translational Medicine (STM), Hong Kong

Essential Science Indicators Field
Clinical Medicine
Published by
Review policy on Publons
  • Does not allow reviews to be publicly displayed
  • Only allows reviewers to display the journal they reviewed for


In accordance with Translational Lung Cancer Research's editorial policy, review content is not publicly displayed on Publons.

Interested in reviewing for this journal?

We can put registered members of Publons' reviewer community in touch with partnered journals they would like to review for. Register now to let Translational Lung Cancer Research know you want to review for them.

Editorial board members on Publons

Publons users have indicated that they sit on Translational Lung Cancer Research's editorial board but we are unable to verify these claims.

Top reviewers on Publons (Manuscripts reviewed in last 12 months)
Endorsed by
Journal/Conference Endorsement